Second Sight Medical Products has a current ratio of 22.15. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Second Sight Medical Products's Current Ratio or its related term are showing as below:
EYESW'
s Current Ratio Range Over the Past 10 Years
Min: 0.7 Med: 3.31 Max: 28.64
Current: 22.15
During the past 10 years, Second Sight Medical Products's highest Current Ratio was 28.64. The lowest was 0.70. And the median was 3.31.
EYESW's Current Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.475
vs EYESW: 22.15
Second Sight Medical Products (NAS:EYESW) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Second Sight Medical Products Current Ratio Related Terms
Second Sight Medical Products Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EYESW vs SONX, LUCD, LHDX: Current Ratio Comparison
For the Medical Devices subindustry, Second Sight Medical Products's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Second Sight Medical Products Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Second Sight Medical Products's Current Ratio distribution charts can be found below:
* The bar in red indicates where Second Sight Medical Products's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Second Sight Medical Products (EYESW) has a Current Ratio of 22.15 as of Jun. 2022. This is 569% above median its historical median of 3.31. Over the past decade, Second Sight Medical Products' Current Ratio has ranged from 0.70 to 28.64.
Is Second Sight Medical Products' Current Ratio too high?
Second Sight Medical Products' current Current Ratio of 22.15 is 569% above median its 10-year median of 3.31. Over the past 10 years, this metric has ranged from a low of 0.70 to a high of 28.64. The Medical Devices & Instruments industry median Current Ratio is 2.48. Second Sight Medical Products' value of 22.15 is 794.9% above this industry median.
How does Second Sight Medical Products' Current Ratio compare to SONX and LUCD?
Second Sight Medical Products' Current Ratio of 22.15 can be compared against companies in the Medical Devices & Instruments industry. The industry median Current Ratio is 2.48. Second Sight Medical Products' value of 22.15 is 794.9% above this benchmark. Historically, Second Sight Medical Products' own Current Ratio has ranged from 0.70 to 28.64 over the past decade. While the company's 10-year median is 3.31 vs. the industry median of 2.48, Second Sight Medical Products has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.48, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Second Sight Medical Products's current Current Ratio of 22.15 is 794.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Second Sight Medical Products's current Current Ratio is 22.15, which is 569% above median its own 10-year median of 3.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Second Sight Medical Products stock overvalued right now?
Second Sight Medical Products (EYESW) has a current Current Ratio of 22.15. The current Current Ratio is 22.15, which is 569% above median its 10-year median of 3.31 and 794.9% above the Medical Devices & Instruments industry median of 2.48. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Second Sight Medical Products (EYESW), the current Current Ratio is 22.15 as of Jun. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Second Sight Medical Products Business Description
Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EYESW has been successfully added to your 